Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Neuronal cell adhesion molecule (NrCAM) is overexpressed in papillary thyroid cancer (PTCs).
• The precise role of NrCAM in thyroid cancer pathogenesis is not fully understood.
• Investigating NrCAM's function is crucial for identifying new diagnostic and therapeutic strategies.

Purpose of the Study:

• To elucidate the biological functions of NrCAM in thyroid cancer.
• To evaluate NrCAM's potential as a diagnostic marker for PTC.
• To explore NrCAM as a therapeutic target for thyroid cancer treatment.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) to assess NrCAM mRNA expression.
• In vitro experiments assessing NrCAM knockdown and ectopic expression in thyroid cancer cells.
• In vivo studies using nude mice and transgenic mice to evaluate tumor growth and invasiveness.

Main Results:

• NrCAM is highly expressed in PTCs, suggesting its potential as a preoperative diagnostic marker.
• NrCAM depletion inhibited thyroid cancer cell growth, invasiveness, and tumorigenicity.
• Ectopic NrCAM expression enhanced tumor-promoting effects by activating MAPK/Erk and PI3K/Akt pathways.
• Positive feedback loops between NrCAM and signaling pathways (MAPK/Erk, PI3K/Akt, GSK3β/β-catenin) were identified, contributing to thyroid tumorigenesis.

Conclusions:

• NrCAM plays a significant role in thyroid tumorigenesis by activating key signaling pathways.
• NrCAM may serve as a valuable diagnostic biomarker for PTC.
• Targeting NrCAM presents a promising therapeutic strategy for thyroid cancer.